10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001104659-15-058233`
Period End Date	20150630
Filing Date	20150810
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	cldx-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 63 Cash Flow Statement 53

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.58M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$40.80M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$173.02M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$252.41M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$427.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$434.00K	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.52M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.12M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$339.54M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$204.99M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	89.59M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	98.55M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	98.55M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$11.73M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$10.54M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	89.59M	shares	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$21.81M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$21.30M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.72M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.68M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$383.22M	USD	Point-in-time
Total Assets	`Assets`	$248.01M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$2.02M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$2.60M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$19.30M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$21.88M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.59M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.79M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$26.69M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$24.49M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$10.65M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$11.86M	USD	Point-in-time
Total Liabilities	`Liabilities`	$36.35M	USD	Point-in-time
Total Liabilities	`Liabilities`	$37.34M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2015 and December 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2015 and December 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 98,548,319 and 89,592,779 Shares Issued and Outstanding at June 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$90.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 98,548,319 and 89,592,779 Shares Issued and Outstanding at June 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$99.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$869.63M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$672.74M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.59M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.62M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.44M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-526.29M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-463.76M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$345.88M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$211.66M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$383.22M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$248.01M	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$334.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$676.00K	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$200.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$235.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.84M	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$773.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.99M	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$392.00K	USD	1 Quarter
Total Revenue	`Revenues`	$1.01M	USD	2 Qtrs
Total Revenue	`Revenues`	$2.66M	USD	2 Qtrs
Total Revenue	`Revenues`	$2.18M	USD	1 Quarter
Total Revenue	`Revenues`	$592.00K	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$51.62M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$26.49M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$24.10M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$51.17M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$4.79M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$14.27M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$8.18M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$9.37M	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$29.14M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$61.05M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$66.39M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$34.93M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-63.73M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-32.75M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-28.55M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-60.04M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$391.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.20M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$275.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.86M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.53M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.36M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.18M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.27M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.65	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$0.65	USD	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.32M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.36M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.48M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	95.48M	shares	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.53M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.36M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.18M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.27M	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-2.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$15.00K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-169.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-180.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$81.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$80.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-28.20M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-62.69M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-58.10M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-32.54M	USD	1 Quarter

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.53M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.36M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.18M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.27M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.38M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.16M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.44M	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.23M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$4.81M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$2.76M	USD	2 Qtrs
Non-Cash Expense	`AmortizationOfDebtDiscountPremium`	$144.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$7.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$36.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.82M	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.84M	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-32.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$98.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.03M	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.52M	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$5.32M	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.01M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-52.73M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-57.35M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$86.34M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.59M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$126.22M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$164.43M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.11M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.09M	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-81.20M	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-76.73M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$188.84M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$856.00K	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$3.26M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$192.10M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$856.00K	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-1.00K	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$15.00K	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-128.60M	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$53.56M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$81.58M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$40.80M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$81.58M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$40.80M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$503.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.